Anne Lewis Carlton, | |
1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 | |
(734) 647-5900 | |
Not Available |
Full Name | Anne Lewis Carlton |
---|---|
Gender | Female |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 1500 E Medical Center Dr, Ann Arbor, Michigan |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003436031 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Anne Lewis Carlton, 1500 E Medical Center Dr Spc 5483, Ann Arbor, MI 48109-5483 Ph: (773) 702-1150 | Anne Lewis Carlton, 1500 E Medical Center Dr, Ann Arbor, MI 48109-5000 Ph: (734) 647-5900 |
News Archive
Jamila K. Stockman, PhD, MPH, assistant professor of medicine and global public health at the University of California, San Diego School of Medicine has been selected to receive the Linda E. Saltzman New Investigator Award.
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, and FBM Industria Farmaceutica Ltda, a member of the HOSPFAR Group that manufactures, imports and distributes pharmaceuticals in Brazil, today announced a license and distribution agreement providing FMBFarma exclusive rights to market Zertane in Brazil for the treatment of premature ejaculation.
Alzheimer's disease is not the only type of dementia. Two particular forms are dementia with Lewy bodies and Parkinson's disease dementia. In both forms, the diagnosis is of vital importance because the treatment for these dementias differs from that for Alzheimer's dementia, as Brit Mollenhauer and co-authors explain in the dementia theme issue of Deutsches -rzteblatt International.
Fat substitutes used in popular snack foods to help people control weight may have the opposite effect, according to Purdue University research.
In a study that involved more than 31,000 women who are carriers of disease-associated mutations in the BRCA1 or BRCA2 genes, researchers identified mutations that were associated with significantly different risks of breast and ovarian cancers, findings that may have implications for risk assessment and cancer prevention decision making among carriers of these mutations, according to a study in the April 7 issue of JAMA.
› Verified 8 days ago